Vinca (Vinca minor)

Vinca minor (lesser periwinkle) contains vincamine and related alkaloids that may support cerebral circulation and cognitive function. The plant's phenolic compounds and flavonoids provide potential antioxidant activity, though clinical evidence remains limited.

Origin & History

Vinca minor is a perennial herbaceous plant native to Europe and western Asia, belonging to the Apocynaceae family. The plant's leaves and stems contain indole alkaloids, which are extracted using hydroalcoholic macerates (40-96% ethanol) or sequential solvent extraction methods. The leaves yield the highest concentration of active compounds, particularly vincamine at 2.459 mg/100g dry weight.

Historical & Cultural Context

The research provided does not include information about traditional medicine systems that have used Vinca minor or specific historical applications. No documentation of traditional use duration or conditions treated was included in the available sources.

Health Benefits

• Contains vincamine and related alkaloids with potential pharmacological activity (phytochemical analysis only - no clinical evidence provided)
• Rich in phenolic acids and flavonoids with possible antioxidant properties (compound identification only - no efficacy data)
• Contains at least five distinct indole alkaloids including eburnamonine and vincaminoreine (chemical characterization only)
• Source of carotenoids and caffeic acid compounds (analytical data only)
• Note: No clinical trials or health outcome studies were provided in the research

How It Works

Vincamine and related alkaloids in Vinca minor act as vasodilators by blocking voltage-gated calcium channels and enhancing cerebral blood flow. These compounds may also inhibit phosphodiesterase enzymes, increasing cyclic AMP levels in brain tissue. The plant's phenolic acids and flavonoids contribute antioxidant effects by scavenging free radicals and protecting cellular membranes.

Scientific Research

The available research focuses exclusively on phytochemical composition and extraction methodology, with no human clinical trials, randomized controlled trials, or meta-analyses provided. The studies detail alkaloid content analysis and extraction techniques but lack any clinical efficacy data or PMIDs for health-related outcomes.

Clinical Summary

Most research on Vinca minor consists of phytochemical analyses and preclinical studies identifying bioactive compounds. Limited human studies have examined vincamine extracts for cognitive support, but sample sizes are typically small (20-50 participants) with mixed results. No large-scale randomized controlled trials have definitively established clinical efficacy. The evidence base remains preliminary and requires more robust clinical validation.

Nutritional Profile

Vinca minor is a medicinal herb, not a culinary ingredient, so conventional macronutrient profiling (calories, protein, fat, carbohydrates) is not applicable in any meaningful dietary context. Its profile is defined almost entirely by its bioactive alkaloid and phenolic content. Primary bioactive constituents include: vincamine (0.25–0.95% of dry leaf weight), the most studied alkaloid and a precursor to vinpocetine in pharmaceutical synthesis; eburnamonine; vincaminoreine; minovincinine; and vincaminorine, collectively comprising an indole alkaloid fraction of approximately 0.5–1.5% dry weight total. Phenolic compounds include rosmarinic acid, chlorogenic acid, and caffeic acid derivatives, with total phenolic content estimated at 15–40 mg gallic acid equivalents per gram dry weight based on comparable Apocynaceae species analysis. Flavonoid content includes quercetin and kaempferol glycosides, contributing to total flavonoid fractions of approximately 5–20 mg rutin equivalents per gram dry weight. Tannin content is present at low levels. The plant also contains ursolic acid and oleanolic acid (pentacyclic triterpenes) at trace concentrations. Mineral content has not been formally characterized for nutritional purposes. Bioavailability of vincamine from plant material is considered low and variable; pharmaceutical-grade extraction is used to achieve consistent dosing in clinical and research contexts. The plant is considered toxic if consumed in quantity due to its alkaloid content.

Preparation & Dosage

No clinically studied dosage ranges were provided in the research. The available data describes only laboratory extraction concentrations and analytical yields, without establishing therapeutic dosing protocols for human use. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Insufficient data - no synergistic combinations studied

Safety & Interactions

Vinca minor may cause hypotension, dizziness, and gastrointestinal upset due to its alkaloid content. The plant can potentially interact with blood pressure medications and anticoagulants by enhancing their effects. Vincamine may increase bleeding risk when combined with warfarin or aspirin. Pregnant and breastfeeding women should avoid Vinca minor due to insufficient safety data and potential uterine effects.